Company Intelligence Profile
Novocura Tech Health Services Private Limited
Novocura Tech Health Services Private Limited is the corporate entity behind mfine, an AI-enabled digital healthcare / telemedicine platform founded in 2017 by Prasad Kompalli and Ashutosh Lawania, offering instant doctor teleconsultations, at-home diagnostic lab tests, medicine delivery, dental/vision care and chroni…
CIN: U85100TN2017PTC166713ActiveRoC Chennai / Tamil Nadu (sources disagree slightly on label: Tofler says "Tamil Nadu", TheCompanyCheck says "Chennai" - same RoC office, confirmed)Confidence: medium
AI OverviewGenerated from public records
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Company Identity
Confirmed| Registered name | Novocura Tech Health Services Private Limited |
|---|---|
| CIN | U85100TN2017PTC166713 |
| PAN | AAFCN4953K (source: TheCompanyCheck first pass only; a second TheCompanyCheck fetch did not surface it — partial/unconfirmed, treat as indicative not certain) |
| Status | Active |
| Listing | Unlisted (private limited company; not listed on any stock exchange) |
| Incorporated | 16 February 2017 (source: Tofler, TheCompanyCheck) |
| ROC | RoC Chennai / Tamil Nadu (sources disagree slightly on label: Tofler says "Tamil Nadu", TheCompanyCheck says "Chennai" - same RoC office, confirmed) |
| Sector (NIC) | Health and Social Work (Section Q); NIC activity codes for "Other IT consulting services n.e.c." and "Other Hospital and Medical Care Activities" — consistent with an AI-enabled telehealth platform (sources: Tofler, TheCompanyCheck) |
| Registered address | No.16, Vijayaraghava Road, I Lane, Thyagarayanagar (T Nagar), Chennai, Tamil Nadu 600017 (sources: Tofler, TheCompanyCheck). Note: this exact address is also LifeCell International's corporate HQ (confirmed via lifecell.in) — a strong corroborating signal for the group affiliation described below, not a data error. |
| Authorized capital | ₹19.53 crore (sources: Tofler, TheCompanyCheck — consistent) |
| Paid-up capital | ₹18.59 crore (sources: Tofler, TheCompanyCheck — consistent) |
Business Overview
Partial / conflicting- Novocura Tech Health Services Private Limited is the corporate entity behind mfine, an AI-enabled digital healthcare / telemedicine platform founded in 2017 by Prasad Kompalli and Ashutosh Lawania, offering instant doctor teleconsultations, at-home diagnostic lab tests, medicine delivery, dental/vision care and chronic-disease-management programs to consumers and corporates (clients cited on mfine.co include Amazon, Honeywell, Nestlé, Uber, American Express)
- In July 2022, mfine merged with LifeCell International's diagnostics business to form a combined entity (reported as "LifeWell"), with OrbiMed investing $80M in the merged unit (source: Entrackr, via DuckDuckGo search snippet, Aug 2026)
- This explains the shared registered address with LifeCell International and the multiple common-director links to LifeCell-group entities found on Tofler (LifeCell International, LifeWell Diagnostics, Cellutions Biostorage, H S Pathology, Creative Art Concepts, Abusha Estates, Amuda Capital Services LLP)
- Financial filings for FY2025 show a sharp (~64%) YoY revenue decline and near-elimination of borrowings/net-worth, consistent with a post-merger wind-down/restructuring of the standalone mfine legal entity rather than a going-concern operating business at prior scale
- Confidence: medium — the merger narrative is corroborated by two independent aggregator/press mentions but full primary-filing confirmation (MCA/XBRL) was not obtained
Directors
Partial / conflictingConfirmed from Tofler/TheCompanyCheck (2 sources agree on names, DINs only partially sourced):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Ashutosh Lawania | 01295011 | Director, DIN 01295011 Tofler; TheCompanyCheck did not show DIN, appointed 16-Feb-2017 since incorporation. Co-founder of mfine; earlier co-founder of LifeCell International. | 16-Feb-2017 |
Financials
Partial / conflicting- FY2025 (audited, standalone, year ending March 2025) — TheCompanyCheck: Revenue ₹18.85 crore (down ~64% YoY)
- Tofler (same filing): revenue bracket "₹10-25 crore", borrowings down 100% (eliminated), total assets down ~85%, book net worth down ~238% (i.e., swung deeply negative), operating margin 98.46%, net profit margin 4.12%, gross margin 0.08%, ROCE 225.75%, debt-to-equity 1.18
- EBITDA and absolute PAT/net-worth/borrowings figures are paywalled on both aggregators ("Financials up to March 2025 available in Tofler Pro") — not obtained as exact values
- Two sources agree directionally (large YoY decline) — confirmed trend, unconfirmed exact absolute figures
- This pattern is consistent with the July 2022 mfine/LifeCell merger reshaping the standalone entity's books
- standalone vs. consolidated treatment for the merged "LifeWell" entity is unclear and not separately confirmed
Funding
Partial / conflictingFunding raised is attributed to the mfine brand/business (pre-merger), not confirmed as filed directly against this CIN in primary MCA records:
| Series A, May 2018 | $4.2M (source: Inventiva, via search snippet) |
|---|---|
| Series B | $17.2M, lead SBI Investment (Japan), with SBI Ven Capital, Beenext, Stellaris Venture Partners, Prime Venture Partners (source: Inventiva) |
| Later round, 31-May-2021 | $48M, led by Beenext, with SBI Group Japan, Stellaris Venture Partners, Heritas Capital, SBI Ven Capital Singapore, Y's Investment, Prime Venture Partners, Alteria Capital (source: AsiaTechDaily) |
| Total raised | Tracxn and TheCompanyCheck agree on ~$87.7M across 9 rounds/30 investors. Inc42 Datalabs reportedly shows "$592.99M+" — this figure is a strong outlier and very likely conflates mfine with the larger combined LifeCell/LifeWell group's cumulative funding (an entity-confusion risk flagged per house rules); NOT used as the headline number |
| Post-merger | OrbiMed invested $80M into the combined mfine+LifeCell diagnostics entity ("LifeWell") in/around July 2022 (source: Entrackr) — this capital sits at the merged-entity level, not confirmed as booked directly under this CIN |
Tracxn used here only for round names/amounts per house rules, cross-checked against press (Inventiva, AsiaTechDaily, Entrackr).
Charges/Loans
Confirmed- Per Tofler: 0 open charges
- 3 satisfied charges totaling ₹46 crore — ₹6 crore (10-Oct-2018), ₹25 crore (14-Jun-2019), ₹15 crore (21-Jan-2021), all marked satisfied
- TheCompanyCheck corroborates "no registered (open) charges." Confirmed (2 sources agree on "no open charges"
- charge amounts/dates from Tofler only)
Legal
Partial / conflicting- One case found on Indian Kanoon: "M/S Avanta Solutions Business Centre vs M/S Novocura Tech Health Services Private Limited," Delhi High Court, heard by Justice Subramonium Prasad, dated 21 May 2026 (per Indian Kanoon listing — note this date is in the future relative to most other data pulled and could be a docket/hearing date rather than judgment date
- not independently verified beyond the single Indian Kanoon search-result summary)
Competitors
ConfirmedMediBuddy (mediBuddy.in) — scale: large, well-funded telehealth leader, reportedly larger revenue base; Practo — scale: large, pan-India doctor-discovery + teleconsult platform; Tata 1mg — scale: large, backed by Tata Digital, pharmacy+diagnostics+teleconsult; Apollo 24|7 — scale: large, hospital-network-backed super-app; DocsApp — scale: mid, teleconsultation-focused (subsequently folded into MediBuddy); Practika/other regional telehealth apps — scale: small-mid. mfine itself, post-2022 merger, is best understood as a shrinking/niche player relative to these after ceding scale to the LifeCell-merged entity.
Frequently Asked Questions
What does Novocura Tech Health Services Private Limited do?
Novocura Tech Health Services Private Limited is the corporate entity behind mfine, an AI-enabled digital healthcare / telemedicine platform founded in 2017 by Prasad Kompalli and Ashutosh Lawania, offering instant doctor teleconsultations, at-home diagnostic lab tests, medicine delivery, dental/vision care and chroni…
What is the CIN of Novocura Tech Health Services Private Limited?
The Corporate Identification Number (CIN) of Novocura Tech Health Services Private Limited is U85100TN2017PTC166713.
Where is Novocura Tech Health Services Private Limited registered?
Novocura Tech Health Services Private Limited is registered with RoC Chennai / Tamil Nadu (sources disagree slightly on label: Tofler says "Tamil Nadu", TheCompanyCheck says "Chennai" - same RoC office, confirmed). Registered address: No.16, Vijayaraghava Road, I Lane, Thyagarayanagar (T Nagar), Chennai, Tamil Nadu 600017 (sources: Tofler, TheCompanyCheck).
When was Novocura Tech Health Services Private Limited incorporated?
Novocura Tech Health Services Private Limited was incorporated on 16 February 2017 (source: Tofler, TheCompanyCheck).
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.